ScreenerHero
WATWaters Corporation
NYSE · US · Healthcare · Diagnostics & Research · waters.com
397.92USD-4.31%Mkt Cap: 40.83B $P/E: 105.81

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromat…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap40.83B $
Enterprise Value44.70B $
Revenue (TTM)4.64B $
Gross Profit1.88B $
Net Income (TTM)642.63M $
Revenue/Share62.10 USD
Last Price397.92 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees16.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS9418481035
Valuation
P/E (Trailing)105.81
P/E (Forward)24.43
PEG1.82
EV/EBITDA30.78
EV/Revenue9.62
P/S8.56
P/B2.62
EPS (TTM)3.97
EPS (Forward)16.56
52W Range
282.7784% of range420.25
52W High420.25 USD
52W Low282.77 USD
Profitability
Gross Margin59.28%
Oper. Margin9.42%
EBITDA Margin31.26%
Profit Margin20.30%
ROE25.09%
ROA12.66%
Growth
Revenue Growth113.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF652.55M $
CapEx (TTM)112.75M $
FCF Margin-3.06%
FCF Yield-0.35%
Net Debt4.94B $
Net Debt/EBITDA3.40
Balance Sheet
Debt/Equity0.58
Current Ratio1.86
Quick Ratio1.05
Book Value/Sh154.70 USD
Cash/Share5.486 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateNov 26, 1996
Pay Date—
Splits
Last Split2:1
Split DateAug 28, 2000
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)436.00 USD
Upside (mean)+9.6%
Target Range349.00 USD – 475.00 USD
$349.00+9.6% to mean$475.00
# Analysts23
Ownership
Shares Out.98.19M
Float98.07M
Insiders0.10%
Institutions102.28%
Short Interest
Short Ratio5.1d
Short % Float4.25%
Short % Out.4.24%
Shares Short4.17M
Short (prev mo.)3.70M
Technical
SMA 50380.29 (+4.6%)
SMA 200358.64 (+11.0%)
Beta1.18
S&P 52W Chg18.16%
Avg Vol (30d)686.52K
Avg Vol (10d)787.22K
Technical Indicators
RSI (14)67.0
MACD11.3735
MACD Signal9.9374
MACD Hist.+1.4361
BB Upper428.73 USD
BB Middle394.48 USD
BB Lower360.23 USD
BB Width17.36%
ATR (14)11.78 USD
Vol Ratio (20d)1.24x